Skip to main content
Caplight Logo









Secura Bio

Secura Bio

Private
Berkeley Heights, New JerseyHealthcare & Life Scienceshttps://securabio.com/

Last Round

Debt

Mar 5, 2019

Total Funding Raised

$145M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Secura Bio is a biopharmaceutical company that develops and commercializes oncology therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

oncology therapiesPI3K inhibitorchronic lymphocytic leukemiaCLLsmall lymphocytic lymphomaSLLdrug commercializationdrug acquisitionbiopharmaceutical companyblood cancershematologic malignanciesrelapsed or refractory cancerthird-line therapydual PI3K inhibitororal oncology drugB-cell malignanciesPeripheral T-cell LymphomaPTCL

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Secura Bio Comparables

Compare Secura Bio with similar companies based on industry and business-model similarity.

Secura Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Yingli Pharmaceutical Co., Ltd.
79%
AbbVie
77%
TG Therapeutics
77%

Secura Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMar 5, 2019
Early FundingMar 5, 2019

Secura Bio Investors

Notable investors and investment history

Secura Bio investors
InvestorRounds
Athyrium Capital ManagementDebt, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 60, 103% of headcount.

  • Jul 25, 2026

    Monthly visitors grew 77% MoM.

Secura Bio Filings

Explore SEC and related filing metadata, where available.

Secura Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Secura Bio's valuation, stock price, and market status.

Is Secura Bio a public or private company?

Secura Bio is a private company.

What is the current stock price of Secura Bio?

Secura Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Secura Bio worth (valuation)?

Valuation information for Secura Bio is not publicly available.

Can I buy Secura Bio stock?

Secura Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Secura Bio's last funding round?

Secura Bio's most recent funding round was Debt on March 5, 2019.

Who are the main investors in Secura Bio?

Investor information for Secura Bio is not publicly disclosed.

Will Secura Bio IPO soon?

No public IPO plans have been announced for Secura Bio.

How can I track Secura Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Secura Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley Heights, New Jersey
Employee Range58
Year Founded2019
Last FundingMar 5, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?